440 related articles for article (PubMed ID: 35487785)
41. Impact of Sphingolipid Mediators on the Determination of Cochlear Survival in Ototoxicity.
Tabuchi K; Hara A
Curr Mol Pharmacol; 2018; 11(4):279-284. PubMed ID: 29766830
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells.
Apraiz A; Idkowiak-Baldys JK; Boyano MD; Pérez-Yarza G; Hannun YA; Asumendi A
BMC Cancer; 2011 Nov; 11():477. PubMed ID: 22061047
[TBL] [Abstract][Full Text] [Related]
43. Sphingolipid metabolic changes during chiral C2-ceramides induced apoptosis in human leukemia cells.
Baek MY; Yoo HS; Nakaya K; Moon DC; Lee YM
Arch Pharm Res; 2001 Apr; 24(2):144-9. PubMed ID: 11339634
[TBL] [Abstract][Full Text] [Related]
44. The sphingosine 1-phosphate receptor 2/4 antagonist JTE-013 elicits off-target effects on sphingolipid metabolism.
Pitman MR; Lewis AC; Davies LT; Moretti PAB; Anderson D; Creek DJ; Powell JA; Pitson SM
Sci Rep; 2022 Jan; 12(1):454. PubMed ID: 35013382
[TBL] [Abstract][Full Text] [Related]
45. Sphingolipids: regulators of crosstalk between apoptosis and autophagy.
Young MM; Kester M; Wang HG
J Lipid Res; 2013 Jan; 54(1):5-19. PubMed ID: 23152582
[TBL] [Abstract][Full Text] [Related]
46. Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials.
Beckham TH; Elojeimy S; Cheng JC; Turner LS; Hoffman SR; Norris JS; Liu X
Expert Opin Ther Targets; 2010 May; 14(5):529-39. PubMed ID: 20334489
[TBL] [Abstract][Full Text] [Related]
47. Sphingolipids in mitochondria.
Hernández-Corbacho MJ; Salama MF; Canals D; Senkal CE; Obeid LM
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Jan; 1862(1):56-68. PubMed ID: 27697478
[TBL] [Abstract][Full Text] [Related]
48. Effects of sphingolipid metabolism disorders on endothelial cells.
Lai Y; Tian Y; You X; Du J; Huang J
Lipids Health Dis; 2022 Oct; 21(1):101. PubMed ID: 36229882
[TBL] [Abstract][Full Text] [Related]
49. Sphingolipids in mammalian cell signalling.
Ohanian J; Ohanian V
Cell Mol Life Sci; 2001 Dec; 58(14):2053-68. PubMed ID: 11814056
[TBL] [Abstract][Full Text] [Related]
50. Targeting glucosylceramide synthase synergizes with C6-ceramide nanoliposomes to induce apoptosis in natural killer cell leukemia.
Watters RJ; Fox TE; Tan SF; Shanmugavelandy S; Choby JE; Broeg K; Liao J; Kester M; Cabot MC; Loughran TP; Liu X
Leuk Lymphoma; 2013 Jun; 54(6):1288-96. PubMed ID: 23181473
[TBL] [Abstract][Full Text] [Related]
51. The Role of Ceramide and Sphingosine-1-Phosphate in Alzheimer's Disease and Other Neurodegenerative Disorders.
Czubowicz K; Jęśko H; Wencel P; Lukiw WJ; Strosznajder RP
Mol Neurobiol; 2019 Aug; 56(8):5436-5455. PubMed ID: 30612333
[TBL] [Abstract][Full Text] [Related]
52. A novel jaspine B-ceramide hybrid modulates sphingolipid metabolism.
Garcia V; Le Faouder P; Dupuy A; Levade T; Ballereau S; Génisson Y
Chem Biodivers; 2015 Jul; 12(7):1115-25. PubMed ID: 26172331
[TBL] [Abstract][Full Text] [Related]
53. Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscle.
Nikolova-Karakashian MN; Reid MB
Antioxid Redox Signal; 2011 Nov; 15(9):2501-17. PubMed ID: 21453197
[TBL] [Abstract][Full Text] [Related]
54. Novel mechanisms of action of classical chemotherapeutic agents on sphingolipid pathways.
Hajj C; Becker-Flegler KA; Haimovitz-Friedman A
Biol Chem; 2015 Jun; 396(6-7):669-79. PubMed ID: 25719313
[TBL] [Abstract][Full Text] [Related]
55. Sphingolipid metabolism and leukemia: a potential for novel therapeutic approaches.
Burns TA; Luberto C
Anticancer Agents Med Chem; 2011 Nov; 11(9):863-81. PubMed ID: 21707485
[TBL] [Abstract][Full Text] [Related]
56. The Critical Impact of Sphingolipid Metabolism in Breast Cancer Progression and Drug Response.
Corsetto PA; Zava S; Rizzo AM; Colombo I
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768427
[TBL] [Abstract][Full Text] [Related]
57. Sphingolipids in inflammation: roles and implications.
Pettus BJ; Chalfant CE; Hannun YA
Curr Mol Med; 2004 Jun; 4(4):405-18. PubMed ID: 15354871
[TBL] [Abstract][Full Text] [Related]
58. Roles of ceramide and sphingolipids in pancreatic β-cell function and dysfunction.
Boslem E; Meikle PJ; Biden TJ
Islets; 2012; 4(3):177-87. PubMed ID: 22847494
[TBL] [Abstract][Full Text] [Related]
59. New Therapeutic Options in Pulmonal Diseases: Sphingolipids and Modulation of Sphingolipid Metabolism.
Kleuser B; Schumacher F; Gulbins E
Handb Exp Pharmacol; 2024; 284():289-312. PubMed ID: 37922034
[TBL] [Abstract][Full Text] [Related]
60. Interdiction of Sphingolipid Metabolism Revisited: Focus on Prostate Cancer.
Voelkel-Johnson C; Norris JS; White-Gilbertson S
Adv Cancer Res; 2018; 140():265-293. PubMed ID: 30060812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
